Summary
- Current Price
- As of today, SBIO price is $62.54, down -1.84% on
- Current Price vs All-Time High
- SBIO price is currently -11.73% below its historical high of $70.85 set on
Profile
| Metric | Value |
|---|---|
| Name | ALPS Medical Breakthroughs ETF |
| Assets Under Management | $133.44M |
| Expense Ratio | 0.50% |
| Asset Class | Equity |
| Domicile | US |
| Inception Date | |
| Net Asset Value | 49.88K USD |
| Website | alpsfunds.com |
| Last Ex-Dividend Date | |
| Next Ex-Dividend Date | N/A |
Top 30 Holdings
| Name | Ticker | Weight |
|---|---|---|
| KYMR | 4.40% | |
| CELC | 3.55% | |
| CGON | 3.33% | |
| ALKS | 3.16% | |
| FOLD | 2.96% | |
| MIRM | 2.96% | |
| APGE | 2.68% | |
| ACAD | 2.50% | |
| VKTX | 2.49% | |
| CRNX | 2.42% | |
| GPCR | 2.34% | |
| NAMS | 2.26% | |
| XENE | 2.16% | |
| SYRE | 2.08% | |
| TARS | 2.08% | |
| EWTX | 1.97% | |
| IDYA | 1.94% | |
| DNLI | 1.93% | |
| DNTH | 1.87% | |
| APLS | 1.70% | |
| VERA | 1.67% | |
| TVTX | 1.63% | |
| IRON | 1.54% | |
| ZLAB | 1.46% | |
| DAWN | 1.45% | |
| MAZE | 1.44% | |
| GLPG | 1.44% | |
| MLYS | 1.40% | |
| STOK | 1.35% | |
| CLDX | 1.31% |
Chart
SUGGESTED SERIES
Technicals
| Metric | Value | Date |
|---|---|---|
| $62.54 | ||
| $56.13 | ||
| $66.33 | ||
| $56.37 | ||
| $65.05 | ||
| -$0.74 | ||
| 1.03 | ||
| $1.59 | ||
| 34.89 | ||
| 20.88% |
Dividends
| Metric | Value | Date |
|---|---|---|
| $1.17 | ||
| Upcoming | N/A | N/A |
| - | ||
| - |
Country Weights
| Country | Weight |
|---|---|
| United States | 84.07% |
| Netherlands | 3.64% |
| Ireland | 3.25% |
| Canada | 2.22% |
| Switzerland | 1.90% |
| Belgium | 1.41% |
| China | 1.41% |
| United Kingdom | 1.22% |
| Germany | 0.87% |
Sector Weights
| Sector | Weight |
|---|---|
| Healthcare | 99.98% |
FAQ
- Does SBIO pay dividends?
- Yes, the ALPS Medical Breakthroughs ETF does pays dividends, with the most recent payment being $1.17 per share. The last ex-dividend date was on December 19, 2024, and the next ex-dividend date has not been announced yet
- What stocks are in SBIO?
- As of today, ALPS Medical Breakthroughs ETF includes 89 holdings, with 85 of them being companies from 9 different countries and 1 sectors. The most weighted holdings are Kymera Therapeutics, Inc. (4.4%), Celcuity Inc. (3.55%) and CG Oncology, Inc. (3.33%)
- What is the current assets under management for SBIO?
- Assets under management of ALPS Medical Breakthroughs ETF is $133M
- What is SBIO average volume?
- Average volume of ALPS Medical Breakthroughs ETF is $16K
- What is SBIO expense ratio?
- Expense ratio of ALPS Medical Breakthroughs ETF is 0.50%
- What is SBIO inception date?
- Inception date of ALPS Medical Breakthroughs ETF is December 30, 2014
Data Sources & References
- SBIO Official Website www.alpsfunds.com/exchange-traded-funds/SBIO
- SBIO Profile on Yahoo Finance finance.yahoo.com/quote/SBIO